Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03659617 · ClinicalTrials.gov registry record · NA

Healing Dynamics in Human Extraction Sockets Grafted With Bio-Oss Collagen®

A NA study of Tooth Loss, sponsored by University of Iowa.

Completed
Registry status
NA
Development phase
39
Enrollment target
1
Study location

NCT03659617: Completed NA study of Tooth Loss, sponsored by University of Iowa.

NCT03659617 is a NA study of Tooth Loss that has completed, run by University of Iowa. The registered enrollment target is 39 participants, below the 101-participant average among 11 other Tooth Loss trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03659617, a NA study of Tooth Loss, has completed, sponsored by University of Iowa.

COMPLETED
Registry status
NA
Development phase
39 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to clinically, radiographically and histologically evaluate the healing sequence of post-extraction sockets grafted with Bio-Oss Collagen® at 3, 6 and 9 months following tooth extraction in single-rooted tooth sites. Subjects with single rooted teeth planned for extraction and replacement with endosseous dental implants will be recruited for the study based on the eligibility criteria and will be divided in three groups (Groups 1, 2 and 3).A cone-beam computed tomography (CBCT) scan will be obtained and reviewed to prepare for the surgical approach and evaluate the ridge dimensions, the tooth planned for extraction as well as the adjacent sites. After tooth extraction, the socket will be grafted with Bio-Oss Collagen® and, depending on the morphology of the extraction sockets, a collagen matrix (Mucograft® seal) and/or a restorable collagen membrane (BioGide®)will be placed to cover and stabilize the graft. Patients will return at 2 and 6 weeks post-extraction to evaluate the healing. A second CBCT will be obtained 2 weeks prior to implant placement to evaluate the ridge dimensions and compare them to the baseline data. Implant placement will take place at 12, 24 and 36 after tooth extraction for Groups 1, 2 and 3 respectively. A bone core biopsy will be obtained at the time of implant placement and will be sent for histological analysis. Patients will return for a post-operative visit at two weeks. Clinical indices (probing depth, recession, bleeding upon probing, keratinized mucosa height, plaque and gingival index), patient reported outcomes and marginal bone levels via standardized periapical radiographs will be evaluated and recorded at baseline (no more than 30 days following delivery of final implant restoration) 1, 2 and 3 years post-loading.

Primary Outcome

For participants that had implant placement, this outcome is determined via clinical evaluation of the number of participants that still had their 1 implant in place after 3 Years. Note: Only 1 implant was placed per participant.

Conditions Studied

Interventions

  • DEVICE xenograft (BioOss Collagen)

Study Locations (1)

Iowa

  • The University of Iowa College of Dentistry and Dental Clinics - Iowa City

Trial Details

FieldValue
Enrollment Target 39 participants
Start Date 2018-12-10
Est. Completion 2025-05-22
Phase NA
University of Iowa

228 total trials

What the finished NCT03659617 record still lists

NCT03659617 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 39 participants, a relatively small participant target, below the 101-participant average among 11 other Tooth Loss trials with a reported enrollment target (61% lower).

The record links to 1 condition, with Tooth Loss appearing as the primary indexed condition, and to 1 intervention - of which xenograft (BioOss Collagen) is the first listed.

NCT03659617 reports a single indexed study location in Iowa.

Frequently Asked Questions

What is clinical trial NCT03659617 about?

NCT03659617 is a clinical study titled "Healing Dynamics in Human Extraction Sockets Grafted With Bio-Oss Collagen®". The purpose of this study is to clinically, radiographically and histologically evaluate the healing sequence of post-extraction sockets grafted with Bio-Oss Collagen® at 3, 6 and 9 months following tooth extraction in single-rooted tooth sites. Subjects with single rooted teeth planned for extract...

What is the current status of trial NCT03659617?

This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2018-12-10. Estimated completion is 2025-05-22.

What conditions does trial NCT03659617 study?

This clinical trial studies the following conditions: Tooth Loss.

What interventions are being tested in trial NCT03659617?

The interventions under investigation include: xenograft (BioOss Collagen) (DEVICE).

Who is sponsoring clinical trial NCT03659617?

This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03659617 being conducted?

This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tooth Loss

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03659617's enrollment target sits among peer trials

39 8th of 11 higher than 4 of 11 other Tooth Loss trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Tooth Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03465592 · 39 participants · Phase 1

    Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma

  • NCT03961776 · 39 participants

    Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems

  • NCT04050280 · 39 participants · Phase 2

    CLAG-GO for Patients With Persistent, Relapsed or Refractory AML

  • NCT04190862 · 39 participants · Phase 1

    E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03659617, the US trial registry maintained by the National Library of Medicine. NCT03659617 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.